Cookies

Like most websites The Pathologist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Subscribe to Newsletter
Diagnostics Analytical science, Biochemistry and molecular biology, Hematology, Screening and monitoring

Unraveling the D-Amino Acid Mystery

Catching chronic kidney disease (CKD) early is critical – patients have a heightened risk of life-threatening cardiovascular diseases and increasingly progress to end-stage kidney disease. But despite an estimated 850 million cases throughout the world (1), the early referral of patients with CKD remains a challenge due to inadequate tests.

In 2016, we reported on a breakthrough in the quest to identify an effective biomarker for early CKD diagnosis: a team from Osaka University found that levels of D-amino acids could predict progression to end-stage kidney disease (2). However, at the time, first author Tomonori Kimura told us “the D-amino acid world is a mystery,” clouding the potential clinical applications of their discovery. Three years on from their initial research, how close have the researchers come to solving that mystery?

D-amino acids are the enantiomers of L-amino acids and – although only trace amounts are present in humans – they are gaining attention as potential biomarkers for a number of diseases. “In our previous study, we saw that the level of D-serine in the blood was well correlated with the estimated glomerular filtration ratio (GFR), which is a key marker of kidney function,” says Kimura. In a new study, the team delved deeper into the diagnostic value of D-serine and applied micro-two-dimensional high-performance liquid chromatography (2D-HPLC) to assess its efficacy as an early indicator of CKD.

D-serine levels in the blood of CKD patients correlated with GFR at a rate equal to or better than existing markers of kidney disease.

Their discovery? That D-serine levels in the blood of CKD patients correlated with GFR at a rate equal to or better than existing markers of kidney disease. In addition, the level of D-serine in the urine provided important information on kidney function other than GFR. “To screen for CKD, it is best to monitor D-serine in both the blood and the urine; it can serve as a dual biomarker for both the prediction of kidney function and the detection of CKD,” Kimura explains.

Current markers for the estimation of GFR include serum creatinine and serum cystatin C – but both are affected by other factors, such as muscular mass. “One of the main advantages of using 2D-HPLC to measure D-serine is its sensitivity and precision – the ability to potentiate absolute quantification removes any small variations in measurements.”

The new research found that the kidney’s balance between excretion and reabsorption of amino acids is controlled by chiral selectivity. This makes the reabsorption of D-serine sensitive to the presence of CKD, allowing testing to distinguish patients with the disease from those without. As we take one step closer to unravelling the mystery of D-amino acids, Kimura believes that there is plenty of potential to fulfill: “Because CKD is prevalent in patients with lifestyle-related diseases, such as diabetes, hypertension, and cardiovascular disease, understanding D-serine is likely to improve prognosis and therapy discovery in these, too.”

Receive content, products, events as well as relevant industry updates from The Pathologist and its sponsors.
Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

  1. A Hesaka et al., “D-Serine reflects kidney function and diseases”, Sci Reports, 9, 5104 (2019). PMID: 30911057.
  2. M Schubert, “A New Angle on CKD”, The Pathologist, 22, 9 (2016). Available at: bit.ly/2FTmn6s.
About the Author
Luke Turner

While completing my undergraduate degree in Biology, I soon discovered that my passion and strength was for writing about science rather than working in the lab. My master’s degree in Science Communication allowed me to develop my science writing skills and I was lucky enough to come to Texere Publishing straight from University. Here I am given the opportunity to write about cutting edge research and engage with leading scientists, while also being part of a fantastic team!

Most Popular
Register to The Pathologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Pathologist magazine

Register